Common infection sits at the center of this dementia and brain health question.
Yes, a common infection your doctor may never connect to dementia could be silently raising your risk right now. Herpes simplex virus (HSV)—the same virus that causes cold sores or genital herpes in millions of people—has been linked to a 36% increased risk of developing dementia, according to a February 2025 study from the University of Texas Medical Branch. More striking: receiving the shingles vaccine reduced new dementia diagnoses by 20% in some populations, suggesting that controlling herpes family viruses may directly lower brain disease risk.
This connection goes unnoticed by most people and many doctors because HSV-1 and HSV-2 are so common—roughly 67% of the global population carries HSV-1—that patients never think to mention a history of cold sores or genital herpes when discussing brain health with their neurologist or primary care doctor. This article examines the infections your doctor may overlook as dementia risk factors, including herpes simplex virus, a respiratory bacterium called Chlamydia pneumoniae that can invade your brain within 72 hours, common urinary tract infections, and even COVID-19. We’ll explain why these infections matter for your brain, how they’re being missed, and what you can do about it starting today.
Table of Contents
- What Common Infections Are Actually Linked to Dementia Risk?
- How Does Chlamydia pneumoniae Sneak Into Your Brain?
- What About Herpes Zoster (Shingles) and Dementia Prevention?
- How Do You Detect These Infections Before They Damage Your Brain?
- What Does the 2024 Lancet Commission Say About Infectious Disease and Dementia?
- What About COVID-19 as an Infection-Related Dementia Risk?
- What Should Change in How Your Doctor Approaches Brain Health?
- Conclusion
- Frequently Asked Questions
What Common Infections Are Actually Linked to Dementia Risk?
The connection between infections and dementia is not new to researchers, but it remains almost invisible in routine clinical practice. A meta-analysis of herpes simplex infections found that individuals with a history of HSV had a pooled hazard ratio of 1.36 for all-cause dementia (meaning 36% higher risk), with a 95% confidence interval of 1.01 to 1.83. What makes this especially overlooked is that both HSV-1 (oral herpes, typically causing cold sores) and HSV-2 (genital herpes) are extremely common, often untreated for years, and patients frequently don’t report them to neurologists. Someone might have had a few cold sores in their twenties and never think about it again—yet that infection could have long-term consequences for brain aging.
Beyond HSV, a 2026 study published in Nature Communications found remarkably high levels of Chlamydia pneumoniae—a common respiratory bacterium—in both the retinas and brains of Alzheimer’s patients compared to cognitively normal individuals. Chlamydia pneumoniae is not an exotic pathogen; it’s a bacterium that causes mild pneumonia, chest infections, and respiratory symptoms in millions of people each year. Patients typically recover and never connect that respiratory illness to their brain health a decade later. The same applies to urinary tract infections (UTIs) and cystitis: a recent study linked these bacterial infections to higher dementia risk, with associations appearing even 25 to 30 years after the initial infection. These are infections treated in outpatient clinics with a course of antibiotics—and then forgotten by both patient and doctor.
How Does Chlamydia pneumoniae Sneak Into Your Brain?
What makes Chlamydia pneumoniae particularly concerning is its pathway into the central nervous system. Once you inhale this bacterium and it establishes an infection in your lungs or respiratory tract, it doesn’t stay there. Research shows that Chlamydia pneumoniae can invade the brain within 72 hours by traveling via the olfactory nerve (your sense of smell) and the trigeminal nerve (the large facial nerve). Once in the brain, it triggers chronic inflammation, causes nerve cell death, and accelerates the buildup of amyloid-beta—the hallmark protein clump that characterizes Alzheimer’s disease. This isn’t a theoretical pathway; a Taiwan cohort study found that antibiotic treatment specifically targeting Chlamydia pneumoniae significantly reduced the risk of Alzheimer’s onset, suggesting that clearing this infection before it damages the brain may be protective.
However, there’s an important caveat: not everyone with a history of Chlamydia pneumoniae infection develops dementia. The elevated risk is statistical, not deterministic. Someone who had a respiratory infection 20 years ago and has no current health problems is not guaranteed to develop Alzheimer’s. Additionally, if you’ve already recovered from the infection and show no current signs of chronic infection, starting antibiotics now would not be appropriate—the damage would likely be long done, and antibiotic overuse carries its own risks. The window of vulnerability appears to be during and shortly after the active infection, making prevention and early detection far more valuable than treating past infections.
What About Herpes Zoster (Shingles) and Dementia Prevention?
The herpes zoster virus (which causes shingles in adults) offers a remarkable case study in infection-related dementia prevention. A Nature study found that individuals who received the herpes zoster vaccine had a 3.5 percentage point reduction in new dementia diagnoses—which translates to a 20% relative risk reduction. This is significant because shingles vaccination is widely available, relatively safe, and now recommended for adults 50 and older by major health organizations.
For a dementia prevention strategy, this represents one of the few infectious disease interventions with measurable protective effect demonstrated in large populations. The herpes zoster vaccine’s protective effect likely works through the same mechanism as HSV’s association: controlling a herpesvirus infection reduces chronic neuroinflammation and helps preserve cognitive function as you age. If you’re over 50 and haven’t received the shingles vaccine (brand name Shingrix), discussing it with your primary care doctor—framing it explicitly as a dementia prevention measure, not just shingles prevention—may open a conversation that doesn’t typically happen. Interestingly, while the vaccine reduces dementia risk substantially, it doesn’t eliminate it entirely, and the specific reasons why some vaccinated people still develop cognitive decline remain under investigation.
How Do You Detect These Infections Before They Damage Your Brain?
The practical challenge is that many of these infections are either past history or mild enough to go unnoticed. For active infections, the answer is straightforward: if you develop respiratory symptoms (persistent cough, chest discomfort, fever), a respiratory infection should be properly evaluated, diagnosed with appropriate testing if needed, and treated—not dismissed as a common cold. The same applies to urinary tract infections: if you have symptoms of cystitis (burning with urination, urgency, frequency), getting a urine culture and appropriate antibiotic treatment is important not just for comfort, but potentially for long-term brain health.
For HSV, the situation is more complex because many people with HSV infections have no symptoms at all (asymptomatic shedding is common). If you know you carry HSV because you’ve had cold sores or a documented genital herpes diagnosis, bringing this up during conversations about dementia risk with your neurologist or primary care doctor could prompt a discussion about whether suppressive antiviral therapy (daily medication to reduce viral reactivation) makes sense for you as a preventive strategy. This is not standard of care yet, but it may become part of the conversation as the evidence linking HSV to dementia becomes more widely known. The tradeoff is that daily antiviral medication carries side effects and costs, whereas the dementia risk reduction from suppression has not yet been quantified in clinical trials.
What Does the 2024 Lancet Commission Say About Infectious Disease and Dementia?
The 2024 Lancet Commission on dementia prevention officially identified infectious disease as a modifiable risk factor that deserves greater clinical attention. This is a major shift in how dementia is understood: instead of viewing it purely as an unavoidable neurodegenerative disease, infectious disease is now recognized as a lever that physicians and patients can actually pull. The Lancet Commission emphasizes that dementia prevention is possible through modification of certain risk factors, and infection management is explicitly included in this list.
The caveat is that this recommendation hasn’t yet transformed clinical practice. Most primary care doctors don’t routinely assess infection history when evaluating dementia risk, and most patients with a history of respiratory infections, UTIs, or herpes don’t receive counseling that these infections might matter for brain health decades later. Additionally, because these infections are common and occur in people who never develop dementia, it can be difficult for individual patients to know whether their specific past infections warrant concern or intervention. What we know is that the association exists at a population level; whether it applies to you depends on factors we don’t yet fully understand.
What About COVID-19 as an Infection-Related Dementia Risk?
COVID-19 introduced a new variable into infection and dementia discussions. A 2025 study published in NPJ Dementia found that COVID-19 survivors had a higher likelihood of developing new-onset dementia compared to uninfected controls. Notably, the elevated dementia risk following COVID-19 was primarily for vascular dementia—dementia caused by reduced blood flow to the brain—rather than Alzheimer’s disease.
This distinction matters because vascular dementia has different underlying mechanisms (blood vessel damage, stroke risk, hypoxia) compared to the amyloid-beta accumulation seen in Alzheimer’s. For people recovering from COVID-19, this finding underscores the importance of managing cardiovascular risk factors (blood pressure, cholesterol, diabetes) aggressively, as these drive vascular dementia risk. The long-term trajectory of COVID-19 survivors and dementia risk remains unclear, as the pandemic is recent and long-term cognitive follow-up studies are still being conducted. Unlike herpes infections or Chlamydia pneumoniae, we don’t yet have data on whether specific treatments reduce dementia risk following COVID-19.
What Should Change in How Your Doctor Approaches Brain Health?
The path forward requires both individual action and systemic change. At the individual level, taking infections seriously—getting respiratory infections properly diagnosed and treated, treating UTIs promptly, maintaining awareness of HSV status, and discussing herpes zoster vaccination with your doctor—are concrete steps. At the clinical level, neurologists and primary care doctors should begin including infection history as part of routine dementia risk assessment, similar to how they currently assess cardiovascular disease, diabetes, and cognitive reserve.
As research continues, we may see more targeted interventions: perhaps suppressive antiviral therapy becomes standard for people with recurrent HSV and no other contraindications, or screening for chronic Chlamydia pneumoniae infection becomes part of dementia prevention protocols. For now, the key is awareness—recognizing that the respiratory infection you had in your forties, or the cold sores you’ve dealt with for decades, or the UTI you treated last year are not separate from your dementia risk. They’re connected, overlooked, and addressable.
Conclusion
The infections your doctor may overlook—herpes simplex virus, Chlamydia pneumoniae, urinary tract infections, and COVID-19—have demonstrated links to increased dementia risk in recent research. These connections matter because these infections are extremely common, often seem minor or are quickly forgotten, and have not traditionally been discussed in the context of brain health.
Yet the evidence from 2025-2026 research is increasingly clear: controlling infections throughout your life may be one of the modifiable factors that influences whether you develop cognitive decline later. The practical steps are within reach: discuss your infection history with your doctor, get the herpes zoster vaccine if you’re over 50, treat active infections promptly, and stay informed as the science evolves. The dementia prevention conversation is shifting from “it’s mostly genetics and luck” toward “there are things you can actually do”—and infection management is now part of that conversation.
Frequently Asked Questions
If I’ve had cold sores for 20 years, is it too late to reduce my dementia risk?
It may not be too late, though the critical window may have passed. The herpes zoster vaccine demonstrates that managing herpesvirus infection even later in life can reduce dementia risk. Discussing whether suppressive antiviral therapy makes sense for your situation with your neurologist is worth exploring, though clear guidelines don’t yet exist.
Should everyone take antibiotics to treat chronic Chlamydia pneumoniae infection?
Not without evidence of active infection. Antibiotic overuse carries risks including antibiotic resistance and side effects. The Taiwan study showing benefit used antibiotics to treat documented Chlamydia pneumoniae infection, not for asymptomatic people. Testing and targeted treatment of confirmed infections is more appropriate than broad prophylaxis.
Does getting the shingles vaccine prevent Alzheimer’s disease outright?
No, the vaccine reduces dementia risk by about 20%, not eliminating it. It’s one protective factor among many. Vaccinated people still develop dementia; the vaccine reduces the probability but doesn’t guarantee prevention.
How long after an infection does dementia risk remain elevated?
Research suggests associations with dementia diagnoses 25 to 30 years after infection, so the window is decades-long. This is why past infections still matter for your current brain health assessment.
Should I start taking antibiotics if I’ve had a respiratory infection?
Only if you have evidence of active infection. Treating a past infection you’ve already recovered from is not indicated. Treating current or chronic infections under medical supervision makes sense, but long-term prophylactic antibiotics for everyone with infection history is not standard care.
Is vascular dementia risk from COVID-19 reversible?
That remains unclear. Managing cardiovascular risk factors aggressively (blood pressure, cholesterol, physical activity) after COVID-19 is the current best practice to reduce vascular dementia risk, but whether existing vascular damage is reversible is still being studied.
You Might Also Like
- The $50 Blood Test That Could Tell You Your Dementia Risk Decades in Advance
- Common Urinary Tract Infections May Increase Your Dementia Risk and Most People Have No Idea
- Why Treating UTIs Early Could Be One of the Simplest Ways to Lower Your Dementia Risk
For more, see CDC — Alzheimer’s and Dementia.
